TA
Tamarack Advisers Portfolio holdings
AUM
$2.12M
This Quarter Return
+2.05%
1 Year Return
-56.28%
3 Year Return
-45.76%
5 Year Return
+44.93%
10 Year Return
–
AUM
$242M
AUM Growth
+$242M
(-22%)
Cap. Flow
-$58.7M
Cap. Flow
% of AUM
-24.22%
Top 10 Holdings %
Top 10 Hldgs %
49.16%
Holding
58
New
15
Increased
6
Reduced
19
Closed
7
Top Buys
| 1 |
Tenet Healthcare
THC
|
$10.2M |
| 2 |
Humana
HUM
|
$9.28M |
| 3 |
BioMarin Pharmaceuticals
BMRN
|
$7.95M |
| 4 |
Viatris
VTRS
|
$6.77M |
| 5 |
Cerus
CERS
|
$6.3M |
Top Sells
| 1 |
Henry Schein
HSIC
|
$28.1M |
| 2 |
PDCO
Patterson Companies, Inc.
PDCO
|
$11.6M |
| 3 |
United Therapeutics
UTHR
|
$10.8M |
| 4 |
MSON
Misonix Inc
MSON
|
$10.1M |
| 5 |
Perrigo
PRGO
|
$9.34M |
Sector Composition
| 1 | Healthcare | 83.89% |
| 2 | Consumer Staples | 3.9% |
| 3 | Consumer Discretionary | 2.27% |
| 4 | Materials | 1.99% |
| 5 | Technology | 1.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Tenet Healthcare
THC
$16.3B
| $16.3M | 6.72% | 200,000 +125,000 | +167% | +$10.2M |
|
2
Pacira BioSciences
PCRX
$1.2B
| $14.4M | 5.94% | 240,000 -135,000 | -36% | -$8.12M |
|
3
Medtronic
MDT
$119B
| $12.9M | 5.32% | 125,000 -75,000 | -38% | -$7.76M |
|
4
Bioventus
BVS
$495M
| $12.7M | 5.21% | 875,000 +395,000 | +82% | +$5.72M |
|
5
SI-BONE Inc
SIBN
$719M
| $12.2M | 5.02% | 550,000 +150,000 | +38% | +$3.33M |
|
6
Rigel Pharmaceuticals
RIGL
$697M
| $11.9M | 4.9% | 4,500,000 -2,500,000 | -36% | -$6.63M |
|
7
Lantheus
LNTH
$3.73B
| $10.3M | 4.22% | 355,000 -35,000 | -9% | -$1.01M |
|
8
AngioDynamics
ANGO
$417M
| $9.52M | 3.91% | 345,000 -5,000 | -1% | -$138K |
|
9
Turning Point Brands
TPB
$1.79B
| $9.45M | 3.88% | 250,000 -25,000 | -9% | -$945K |
|
|
10
Humana
HUM
$36.5B
| $9.28M | 3.81% | +20,000 | New | +$9.28M |
|
|
11
BioMarin Pharmaceuticals
BMRN
$11.2B
| $7.95M | 3.27% | +90,000 | New | +$7.95M |
|
|
STRM
12
DELISTED
Streamline Health Solutions
STRM
| $7.35M | 3.02% | 4,930,882 | – | – |
|
13
AtriCure
ATRC
$1.84B
| $6.95M | 2.86% | 100,000 -17,000 | -15% | -$1.18M |
|
|
14
Cerus
CERS
$251M
| $6.81M | 2.8% | 1,000,000 +925,000 | +1,233% | +$6.3M |
|
|
15
Viatris
VTRS
$12.3B
| $6.77M | 2.78% | +500,000 | New | +$6.77M |
|
|
VRAY
16
DELISTED
ViewRay, Inc.
VRAY
| $6.61M | 2.72% | 1,200,000 -400,000 | -25% | -$2.2M |
|
17
Topgolf Callaway Brands
MODG
$1.76B
| $5.49M | 2.26% | 200,000 -250,000 | -56% | -$6.86M |
|
18
Merck
MRK
$210B
| $5.37M | 2.21% | +70,000 | New | +$5.37M |
|
19
McKesson
MCK
$85.4B
| $4.97M | 2.04% | +20,000 | New | +$4.97M |
|
20
ScottsMiracle-Gro
SMG
$3.53B
| $4.83M | 1.99% | +30,000 | New | +$4.83M |
|
21
Baxter International
BAX
$12.7B
| $4.29M | 1.76% | +50,000 | New | +$4.29M |
|
22
CVS Health
CVS
$92.8B
| $4.13M | 1.7% | +40,000 | New | +$4.13M |
|
23
Plexus
PLXS
$3.7B
| $4.03M | 1.66% | 42,000 +2,000 | +5% | +$192K |
|
|
ISEE
24
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $3.76M | 1.55% | 225,000 -25,000 | -10% | -$418K |
|
|
MDRX
25
DELISTED
Veradigm Inc. Common Stock
MDRX
| $3.69M | 1.52% | 200,000 -375,000 | -65% | -$6.92M |
|